This #IndependenceDay we honor those living with #ALS who have served our country, like Elizabeth Fassler, a U.S. Army Veteran who now serves the ALS community by spreading awareness of this disease. Thank you for your service!
Mitsubishi Tanabe Pharma America
Pharmaceutical Manufacturing
Jersey City, NJ 14,297 followers
About us
We are taking on the challenges of complex and debilitating conditions and are committed to meeting the needs of people suffering from serious and often life-threatening illnesses. Today, we are focused on driving scientific discovery in many areas. Our focus remains on bringing treatment to people living with ALS as we strive to make a meaningful difference in their lives. Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs. We continue to expand our work to deepen our understanding of ALS, explore potential biomarkers to aid in further research and seek new answers. Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses. Please see our LinkedIn community guidelines here: http://www.mt-pharma-america.com/pdf/LinkedIn-Community-Guidelines.pdf
- Website
-
https://www.mt-pharma-america.com/
External link for Mitsubishi Tanabe Pharma America
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Jersey City, NJ
- Type
- Privately Held
- Founded
- 2016
- Specialties
- pharmaceutical products, amyotrophic lateral sclerosis, rare disease, innovation, research and development, and global business
Locations
-
Primary
Jersey City, NJ, US
Employees at Mitsubishi Tanabe Pharma America
-
Howard Levine
Associate Director,Healthcare Intelligence | Digital Biomarkers | Wearables | Decentralized Clinical Trials 🏠 | Beyond the Pill 💊 | Health IoT 📱
-
Glenn Bubb
-
Lia Thornton
Sr. Director, Multichannel Marketing & Patient Support at Mitsubishi Tanabe Pharma America
-
Gayatri Bhasin
Associate Director, Multichannel Marketing & Patient Support
Updates
-
Tomorrow marks the 85th anniversary of Lou Gehrig’s farewell speech after being diagnosed with #ALS. His story continues to inspire hope in the ALS community, and in honor of Lou’s memory, our team is attending the Reds vs. Yankees game on July 4th to raise awareness for ALS.
-
Craig Fuchs, a former band and orchestra director recently shared how connecting with other #pALS helped him throughout his #ALS journey. Learn more about his experience in our latest article with The Mighty here: https://bit.ly/4cJJ21M
-
We’re on-site at the 2024 European Academy of Neurology Congress. Visit us at booth E10 to connect and learn more about our commitment to #ParkinsonsDisease. To learn more about MTPA’s plans at EAN, visit: https://bit.ly/3VDmDMy
-
-
We look forward to connecting with the scientific community at the 2024 European Academy of Neurology Congress in Helsinki, Finland this year, where we will be sharing findings from our ongoing #ParkinsonsDisease research. To learn more about our plans, visit: https://bit.ly/3VDmDMy
-
We’re looking forward to attending the #ATMRD2024 Congress in Washington, D.C.! MTPA will be on-site presenting abstracts in #ParkinsonsDisease (PD). Visit us in the exhibit hall to learn more about our commitment to PD.
-
Explore our recent announcement. Learn more here: https://bit.ly/4ctFf8n
-
Receiving an #ALS diagnosis can be overwhelming, impacting the person diagnosed and their family. We strive to make a positive difference in the lives of people living with #ALS by advancing research. Learn more here: bit.ly/4d0SSNs
-
Access to real-world data can support healthcare decision making for complex diseases like #ALS. Learn more about how we’re advancing research with #RWD here: https://bit.ly/4en7tU9
-
This week is the second anniversary for one of our #ALS treatment options. We’re grateful to serve the ALS community and offer a treatment option for people with #ALS! Learn more about our ongoing commitment to supporting the ALS community: https://bit.ly/3xoO6cL